Trump's Drug Price Policy Forces AstraZeneca to Adjust Pricing Strategy
July 27, 2026·about 1 hour ago·via Reuters

AstraZeneca executives are openly acknowledging that the Trump administration's Most Favored Nation (MFN) drug pricing policy is reshaping how the pharmaceutical giant prices its medications. This is exactly what America First policy is supposed to do - force Big Pharma to stop price gouging American patients while charging foreigners a fraction of the cost. For years, globalist bureaucrats and their corporate allies claimed market-based pressure couldn't work on drug prices. Read more about this...